Stada Group
Oliwia Caruso is an accomplished Quality Assurance Manager at STADA Group since April 2021, with previous experience as Leitung Qualitätssicherung at THC Pharm GmbH (Canopy Growth Corporation) from September 2015 to March 2021. Oliwia holds a Master of Engineering in Bio- und Umweltverfahrenstechnik from RheinMain University of Applied Sciences, obtained between 2013 and 2015, and a Bachelor of Engineering in Management und Produktionsingenieurwesen from Wroclaw University of Economics and Business, completed from 2008 to 2012.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.